Tanaka, Akio, et al. “Lebrikizumab Combined With Topical Corticosteroids Improves Patient-Reported Outcomes in Japanese Patients With Moderate-to-Severe Atopic Dermatitis”. Acta Dermato-Venereologica, vol. 104, Sept. 2024, p. adv34375, doi:10.2340/actadv.v104.34375.